ArticleBMC family practice2016
Factors influencing deprescribing for residents in Advanced Care Facilities: insights from General Practitioners in Australia and Sweden.
Article in BMC family practice, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- How do aged-care staff feel about antimicrobial stewardship? A systematic review of staff attitudes in long-term residential aged-care.Antimicrobial resistance and infection control · 2022Pooled it
- Understanding GPs' clinical reasoning processes involved in managing patients suffering from multimorbidity: A systematic review of qualitative and quantitative research.International journal of clinical practice · 2021Pooled it
- Health care professionals' attitudes towards deprescribing in older patients with limited life expectancy: A systematic review.British journal of clinical pharmacology · 2019Pooled it
- Attitudes and confidence toward deprescribing: a survey among Italian general practitioners.BMC primary care · 2025Observational
- Exploration of Perceptions of Deprescribing Practices Among Doctors in a Low- and Middle-Income Country: A Mixed-Methods Study.Basic & clinical pharmacology & toxicology · 2025Article
- Barriers to Deprescribing Benzodiazepines in Older Adults in a Survey of European Physicians.JAMA network open · 2025Article
- Older Adults' Attitudes Toward Deprescribing in 14 Countries.JAMA network open · 2025Article
- Physicians and hospital pharmacists' knowledge, attitudes, and practices towards polypharmacy in older patients with chronic diseases.Scientific reports · 2024Article
- Drug-Related Problems and Recommendations Made during Home Medicines Reviews for Sick Day Medication Management in Australia.Medicina (Kaunas, Lithuania) · 2024Article
- Development and validation of the Medical Attitudes Towards Deprescribing Questionnaire.Internal and emergency medicine · 2024Article
- Differences in Factors Influencing Deprescribing between Primary Care Providers: Cross-Sectional Study.International journal of environmental research and public health · 2023Article
- Psychotropic medication deprescribing in residential aged care facilities: An exploratory study of the knowledge and attitudes of family members of residents with dementia.Australasian journal on ageing · 2022Article
- Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.Health technology assessment (Winchester, England) · 2022Review
- Development and Validation of Comprehensive Healthcare Providers' Opinions, Preferences, and Attitudes towards Deprescribing (CHOPPED Questionnaire).Pharmacy (Basel, Switzerland) · 2022Article
- Physicians' perceived barriers and enablers for deprescribing among older patients at public primary care clinics: a qualitative study.International journal of clinical pharmacy · 2022Article
- Article
- General practitioners' deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries.BMC geriatrics · 2021Article
- Perspectives of health professionals towards deprescribing practice in Asian nursing homes: a qualitative interview study.BMJ open · 2019Article
- Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland.BMC family practice · 2019Article
- Antidepressant and antipsychotic prescribing in primary care for people with dementia.Canadian family physician Medecin de famille canadien · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGeneral Practitioners (GPs) are responsible for primary prescribing decisions in most settings. Elderly patients living in Advanced Care Facilities (ACFs) often have significant co-morbidities to consider when selecting an appropriate drug therapy. Careful assessment is required when considering appropriate medication use in frail older patients as they have multiple diseases and thus multiple medication. Many physicians seem reluctant to discontinue other physicians' prescriptions, resulting in further polypharmacy. Therefore it is relevant to ascertain and synthesise the GP views from multiple settings to understand the processes that might promote appropriate deprescribing medications in the elderly. The aims of this study were to 1) compare and contrast behavioural factors influencing the deprescribing practices of GPs providing care for ACF residents in two separate countries, 2) review health policy and ACF systems in each setting for their potential impact on the prescribing of medications for an older person in residential care of the elderly, and 3) based on these findings, provide recommendations for future ACF deprescribing initiatives.
methodsA review and critical synthesis of qualitative data from two interview studies of knowledge, attitudes, and behavioural practices held by GPs towards medication management and deprescribing for residents of ACFs in Australia and Sweden was conducted. A review of policies and health care infrastructure was also carried out to describe the system of residential aged care in the both countries.
resultsOur study has identified that deprescribing by GPs in ACFs is a complex process and that there are numerous barriers to medication reduction for aged care residents in both countries, both with similarities and differences. The factors affecting deprescribing behaviour were identified and divided into: intentions, skills and abilities and environmental factors.
conclusionsIn this study we show that the GPs' behaviour of deprescribing in two different countries is much dependent on the larger health care system. There is a need for more education to both GPs and ACF staff as well as better cooperation between the different health care systems and appropriate monetary incentives for elderly care to achieve better conditions for deprescribing practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.